A 71-year-old man with severe kidney failure died from methotrexate poisoning after receiving standard arthritis medication doses without kidney function testing or monitoring. According to Gram Research analysis of this case report, his kidneys couldn’t eliminate the drug, causing it to accumulate to lethal levels and triggering bone marrow failure, severe infection, and organ shutdown within days. This tragedy demonstrates that methotrexate is contraindicated in end-stage kidney disease and that mandatory kidney testing before treatment and regular monitoring are essential to prevent fatal toxicity.
A 71-year-old man with severe arthritis and failing kidneys died after receiving a standard dose of methotrexate, a common arthritis medication. According to Gram Research analysis, his kidneys couldn’t clear the drug from his body, causing it to build up to toxic levels. Within days, he developed severe nausea, mouth sores, and bone marrow failure. This tragic case shows that doctors must check kidney function before prescribing methotrexate and monitor patients carefully, especially older adults with kidney disease. The medication is simply too dangerous for people with end-stage kidney failure without special precautions.
Key Statistics
A 2026 case report published in Medicine documented a fatal methotrexate poisoning in a 71-year-old patient with end-stage renal disease who received standard 10 mg weekly doses without kidney function assessment or folic acid supplementation.
In the reported case, serum methotrexate levels remained dangerously elevated six days after the final dose, confirming severe drug accumulation due to kidney failure and demonstrating that conventional-dose methotrexate is contraindicated in end-stage renal disease patients.
The patient developed severe toxicity symptoms within 24 hours of his final methotrexate injection, including persistent nausea, vomiting, extensive oral ulcers, and bone marrow suppression, progressing to septic shock and multiple organ failure despite intensive medical intervention.
The Quick Take
- What they studied: Whether a standard dose of methotrexate (a rheumatoid arthritis drug) is safe for elderly patients with complete kidney failure
- Who participated: One 71-year-old man with rheumatoid arthritis who had untreated stage 5 chronic kidney disease (the most severe kidney failure)
- Key finding: The patient died from methotrexate poisoning because his failing kidneys couldn’t eliminate the drug, causing it to accumulate to lethal levels in his body
- What it means for you: If you have kidney disease and take methotrexate for arthritis, your doctor must test your kidney function regularly and adjust your dose or stop the medication. Never skip folic acid supplements, which help protect against methotrexate toxicity. This case is a warning, not a reason to panic—proper monitoring prevents this tragedy.
The Research Details
This is a case report, which means doctors documented what happened to one specific patient to teach others. The patient was a 71-year-old man with rheumatoid arthritis who had severe kidney disease that went untreated for a year. He received three weekly injections of methotrexate at a standard 10 mg dose without blood tests to monitor drug levels or folic acid supplements to reduce side effects.
Methotrexate normally leaves your body through your kidneys. When kidneys don’t work, the drug stays in your system and builds up like water behind a dam. In this case, doctors didn’t check kidney function before prescribing the medication, which is a critical safety step. The patient developed severe poisoning symptoms within 24 hours of his last injection.
Case reports are important because they document rare but serious events that might not show up in larger studies. This case matters because it shows a preventable death—proper kidney testing and monitoring could have saved this man’s life. It serves as a warning to all doctors prescribing methotrexate to check kidney function first, especially in elderly patients.
This is a single case, so we can’t say how often this happens. However, the medical facts are clear: the patient’s blood tests showed extremely high methotrexate levels, confirming the drug accumulated due to kidney failure. The case is well-documented and published in a medical journal, making it reliable for teaching purposes. The main limitation is that one case can’t tell us the exact risk for all kidney patients on methotrexate—we’d need larger studies for that.
What the Results Show
The patient received three weekly injections of 10 mg methotrexate without any kidney function tests beforehand. One day after his final injection, he developed severe nausea, vomiting, painful mouth sores, a skin rash, and extreme drowsiness. His bone marrow stopped producing blood cells properly, leading to severe infection (septic shock) and failure of multiple organs including his heart and lungs.
Blood tests showed methotrexate levels remained dangerously high six days after his last dose—proof that his kidneys couldn’t clear the drug. Doctors gave him intensive treatment including a rescue medication (leucovorin calcium), dialysis to try removing the drug, antibiotics, blood transfusions, and a breathing machine. Despite all these efforts, his body couldn’t recover from the damage. He died from overwhelming infection and organ failure.
This case demonstrates that even a ‘standard’ or ’low’ dose of methotrexate becomes a lethal poison in patients with complete kidney failure. The drug accumulated to toxic levels because the kidneys—the main route for eliminating methotrexate—weren’t working.
The patient never received folic acid supplements, which reduce methotrexate’s toxic effects. He had no regular blood tests to catch the problem early. These two missing safety measures made the situation worse. The case also shows that elderly patients may be more vulnerable to methotrexate toxicity, though more research is needed to confirm this.
Medical literature has documented methotrexate toxicity in kidney patients before, but fatal cases in elderly people receiving standard doses remain uncommon and underreported. This case reinforces what doctors already know: methotrexate is contraindicated (should not be used) in end-stage kidney disease. However, it highlights that the warning isn’t always followed in practice, and some doctors may not realize how dangerous even low doses can be.
This is a single case, not a study of many patients, so we can’t calculate how often this happens or identify all risk factors. We don’t know if this patient had other health conditions that increased his risk. The case doesn’t tell us whether adjusted doses or more frequent monitoring could have made methotrexate safe for him. To truly understand the risks, researchers would need to study many kidney patients on methotrexate.
The Bottom Line
Strong recommendation: If you have kidney disease and take methotrexate for arthritis, your doctor must test your kidney function before starting the medication and regularly during treatment. Take folic acid supplements as prescribed—they significantly reduce methotrexate side effects. If your kidney function declines, methotrexate should be stopped or the dose drastically reduced. High confidence: This case proves that standard doses are unsafe in complete kidney failure.
This warning applies most urgently to people with stage 4-5 chronic kidney disease (severe kidney failure) who take or might take methotrexate. Rheumatologists and emergency room doctors should use this case to review their safety protocols. Elderly patients with kidney disease are at highest risk. People with mild-to-moderate kidney disease should discuss with their doctor whether methotrexate is appropriate and ensure regular monitoring.
Toxicity symptoms appeared within 24 hours of the last dose. Organ failure developed over several days. This is not a slow process—methotrexate poisoning in kidney patients is a medical emergency. If you experience severe nausea, vomiting, mouth sores, or unusual bleeding after methotrexate, seek emergency care immediately.
Frequently Asked Questions
Is methotrexate safe for people with kidney disease?
Methotrexate is contraindicated in end-stage kidney disease because kidneys eliminate the drug, and failure to clear it causes toxic accumulation. A 2026 case report documented a fatal poisoning in a patient with complete kidney failure. People with mild-to-moderate kidney disease may tolerate adjusted doses with careful monitoring, but kidney function must be tested before starting and regularly during treatment.
What are the warning signs of methotrexate toxicity?
Severe nausea, vomiting, painful mouth sores, skin rash, unusual bleeding or bruising, and extreme drowsiness are red flags. In the documented case, these symptoms appeared within 24 hours of injection. Seek emergency care immediately if you experience these symptoms while taking methotrexate, especially if you have kidney disease.
Can folic acid prevent methotrexate poisoning in kidney patients?
Folic acid supplements reduce methotrexate side effects and toxicity risk, but they cannot prevent poisoning in patients with complete kidney failure. The patient in this case received no folic acid supplementation. Folic acid is essential but not sufficient—kidney function testing and dose adjustment are mandatory for safety.
How often should kidney function be tested if I take methotrexate?
Blood tests for kidney function (creatinine and eGFR) should be performed before starting methotrexate and then every 1-3 months during treatment, depending on your baseline kidney function and risk factors. The fatal case involved no pre-treatment testing, which was a critical safety failure. Discuss the appropriate monitoring schedule with your rheumatologist.
What should I do if my kidney function declines while taking methotrexate?
Notify your rheumatologist immediately—do not wait for your next scheduled appointment. Declining kidney function may require stopping methotrexate or significantly reducing the dose. The documented case shows that standard doses become lethal when kidneys fail, making prompt medical review essential for your safety.
Want to Apply This Research?
- If you take methotrexate, track your kidney function test results (creatinine and eGFR numbers) every 1-3 months. Log the date, values, and any symptoms like nausea or mouth sores. Set reminders for scheduled blood work so you never miss monitoring.
- Set a daily reminder to take your folic acid supplement on the days you don’t take methotrexate. Create a medication log showing your methotrexate dose and injection dates. Share your kidney function numbers with your rheumatologist at every visit and ask specifically: ‘Is methotrexate still safe for my kidney function?’
- Establish a quarterly review where you compare your kidney function trend over time. If creatinine is rising or eGFR is falling, flag this for your doctor immediately. Keep a symptom diary noting any nausea, vomiting, mouth sores, or unusual fatigue. Report new symptoms to your doctor within 24 hours rather than waiting for your next appointment.
This case report documents a tragic but rare event and should not cause panic among people taking methotrexate with normal kidney function. However, if you have kidney disease and take methotrexate, this case underscores the critical importance of kidney function testing before treatment and regular monitoring during therapy. Never stop or change your methotrexate dose without consulting your doctor. If you experience severe nausea, vomiting, mouth sores, or unusual bleeding while taking methotrexate, seek emergency medical care immediately. This information is educational and not a substitute for medical advice from your healthcare provider.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.